L, L., BB, Z., LS, M., X, S., JJ, C., WD, X., & X, L. (2014). Telekin suppresses human hepatocellular carcinoma cells in vitro by inducing G2/M phase arrest via the p38 MAPK signaling pathway. Acta pharmacologica Sinica, 35(10), 1311. https://doi.org/10.1038/aps.2014.74
Chicago Style (17th ed.) CitationL, Li, Zheng BB, Ma LS, Sun X, Chang JJ, Xie WD, and Li X. "Telekin Suppresses Human Hepatocellular Carcinoma Cells in Vitro by Inducing G2/M Phase Arrest via the P38 MAPK Signaling Pathway." Acta Pharmacologica Sinica 35, no. 10 (2014): 1311. https://doi.org/10.1038/aps.2014.74.
MLA (9th ed.) CitationL, Li, et al. "Telekin Suppresses Human Hepatocellular Carcinoma Cells in Vitro by Inducing G2/M Phase Arrest via the P38 MAPK Signaling Pathway." Acta Pharmacologica Sinica, vol. 35, no. 10, 2014, p. 1311, https://doi.org/10.1038/aps.2014.74.